MedTrace Logo

Reperfusion With Hypothermia in Acute Ischemic Stroke

NCT05676957 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-01-11

No results posted yet for this study

Summary

The primary objective of this study is to determine the feasibility and safety of receiving intravascular hypothermia treatment for patients experiencing endovascular treatment after acute ischemic stroke(AIS) due to a large vessel occlusion.

Conditions

  • Ischemic Stroke
  • Revascularization
  • Endovascular Treatment
  • Reperfusion Injury

Interventions

DEVICE

Thermogard XP3

Patients received endovascular hypothermia for 12 hours following endovascular treatment and recanalization.

Sponsors & Collaborators

  • Liping Liu

    lead OTHER

Principal Investigators

  • Liping Liu · Beijing Tiantan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-03-01
Completion
2024-03-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05676957 on ClinicalTrials.gov